Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0037116 (silicosis)
 1,822 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The building industry entails the exposure to Respirable Crystalline Silica (RCS), though there is a large variability among different sectors. The environmental values reported for the current conditions seem to be relatively low. For example the mean exposure estimated by IOM for all industrial sectors in the EU is 0.07 mg/m3. There are few studies in the building sector which show similar values. This is obviously not representative of past exposure. Moreover, the problems of sampling and analysis techniques are still at issue. The well known effect of RCS exposure is silicosis. The carcinogenicity of RCS is still under debate, especially regarding the question of whether RCS is carcinogenic "per se" or whether the risk of developing lung cancer is mediated by silicosis. Although the IARC includes RCS in the Group I (human carcinogen), the reference should be the CLP regulation, of which carcinogen definition criteria allow to state that today there are not sufficient data to classify RCS as a carcinogen and that it seems more appropriate to include RCS in different STOT.RE categories. This is valid for building industry as well as for the other industrial sectors. In Italy the recommended exposure limit is the ACGIH value of 0.025 mg/m3. At EU level it is still debated which is the best choice, based on cost/benefits evaluation, among the following limit values: 0.2, 0.1 and 0.05 respectively. The authors obviously believe that the most protective value should be adopted.
 ...
PMID:[The evaluation of biological effects of exposure to respirable crystalline silica in building industry]. 2321 7